Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Dec-08 4:07 PM View:  | Taub Rebecca SVP, Research & Development | VIA Pharmaceuticals, Inc. (VIAP) | 17-Dec-08 | Grant | 125,000 | -- | -- | 385% 32.5K to 157.5K | |
| 19-Dec-08 4:04 PM View: | Cohen Lawrence Kenneth CEO and President Director | VIA Pharmaceuticals, Inc. (VIAP) | 17-Dec-08 | Grant | 300,000 | -- | -- | 251% 119.66K to 419.66K | |
| 19-Dec-08 4:05 PM View: | Stewart James Gordon SVP, CFO and Secretary | VIA Pharmaceuticals, Inc. (VIAP) | 17-Dec-08 | Grant | 125,000 | -- | -- | 135% 92.93K to 217.93K | |
| 19-Dec-08 4:07 PM View: | Taub Rebecca SVP, Research & Development | VIA Pharmaceuticals, Inc. (VIAP) | 05-Dec-08 | Market Purchase | 32,500 | $0.30 | $9,750.00 | 100% 0 to 32.5K | 25% |
| 07-Nov-07 6:31 PM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 06-Nov-07 | Market Sale | 63,138 | $3.21 | $202,673.00 | (3%) 2.03M to 1.97M | 88% |
| 07-Nov-07 6:31 PM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 05-Nov-07 | Market Sale | 100 | $3.38 | $337.50 | (< 1%) 2.03M to 2.03M | 89% |
| 02-Nov-07 6:58 PM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 31-Oct-07 | Market Sale | 116 | $3.96 | $459.94 | (< 1%) 2.03M to 2.03M | 90% |
| 30-Oct-07 7:27 PM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 26-Oct-07 | Market Sale | 2,307 | $3.92 | $9,051.75 | (< 1%) 2.04M to 2.03M | 90% |
| 26-Oct-07 10:13 AM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 25-Oct-07 | Market Sale | 2,149 | $3.88 | $8,329.52 | (< 1%) 2.04M to 2.04M | 90% |
| 26-Oct-07 10:13 AM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 24-Oct-07 | Market Sale | 13,167 | $3.91 | $51,542.20 | (< 1%) 2.05M to 2.04M | 90% |
| 26-Oct-07 10:13 AM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 23-Oct-07 | Market Sale | 100 | $3.96 | $396.50 | (< 1%) 2.05M to 2.05M | 90% |
| 26-Oct-07 10:13 AM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 22-Oct-07 | Market Sale | 704 | $3.98 | $2,801.85 | (< 1%) 2.05M to 2.05M | 91% |
| 19-Oct-07 8:05 PM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 18-Oct-07 | Market Sale | 920 | $3.98 | $3,661.51 | (< 1%) 2.05M to 2.05M | 91% |
| 19-Oct-07 8:05 PM View: | Flynn James E 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 17-Oct-07 | Market Sale | 5,425 | $4.03 | $21,837.70 | (< 1%) 2.06M to 2.05M | 91% |
| 08-Aug-07 8:18 PM View: | Bay City Capital LLC 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 08-Aug-07 | Private Purchase | 784,831 | $2.43 | $1,907,140.00 | 7% 11.67M to 12.46M | |
| 10-Aug-07 1:27 PM View: | Anderson Richard L Director | VIA Pharmaceuticals, Inc. (VIAP) | 08-Aug-07 | Private Purchase | 10,000 | $2.43 | $24,300.00 | 100% 0 to 10.0K | |
| 08-Aug-07 8:18 PM View: | Bay City Capital LLC 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 08-Aug-07 | Private Purchase | 3,281,150 | $2.43 | $7,973,200.00 | 39% 8.39M to 11.67M | |
| 07-Jun-07 5:05 PM View: | Given Douglas B Director | VIA Pharmaceuticals, Inc. (VIAP) | 05-Jun-07 | Grant | 122,867 | -- | -- | 100% 0 to 122.87K | |
| 07-Jun-07 2:08 PM View: | Bay City Capital LLC 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 05-Jun-07 | Acquisition (other) | 1,620,130 | -- | -- | 24% 6.77M to 8.39M | |
| 07-Jun-07 5:02 PM View: | Cohen Lawrence Kenneth CEO and President Director | VIA Pharmaceuticals, Inc. (VIAP) | 05-Jun-07 | Grant | 119,660 | -- | -- | 100% 0 to 119.66K | |
| 07-Jun-07 5:06 PM View: | Stewart James Gordon SVP, CFO and Secretary | VIA Pharmaceuticals, Inc. (VIAP) | 05-Jun-07 | Grant | 92,930 | -- | -- | 100% 0 to 92.93K | |
| 07-Jun-07 5:03 PM View: | Olukotun Adeoye Y Chief Medical Officer | VIA Pharmaceuticals, Inc. (VIAP) | 05-Jun-07 | Grant | 59,624 | -- | -- | 100% 0 to 59.62K | |
| 07-Jun-07 2:08 PM View: | Bay City Capital LLC 10% Owner | VIA Pharmaceuticals, Inc. (VIAP) | 05-Jun-07 | Acquisition (other) | 6,773,300 | -- | -- | 100% 0 to 6.77M | |
| 28-Jan-05 4:41 PM View: | Larson John Randolph Director | VIA Pharmaceuticals, Inc. (VIAP) | 26-Jan-05 | Option Exercise | 9,970 | $1.75 | $17,447.50 | 17% 59.23K to 69.2K | |
| 28-Jan-05 4:41 PM View: | Larson John Randolph Director | VIA Pharmaceuticals, Inc. (VIAP) | 26-Jan-05 | Payment of Exercise | 3,330 | $5.24 | $17,449.20 | (5%) 69.2K to 65.87K | 100% |
| 25-Jan-05 4:31 PM View: | Schmitt Victor W Director | VIA Pharmaceuticals, Inc. (VIAP) | 21-Jan-05 | Option Exercise | 90 | $5.25 | $472.50 | < 1% 14.73K to 14.82K | (100%) |
| 24-Jan-05 11:52 AM View: | Atwood Robert T CFO, Executive VP Director | VIA Pharmaceuticals, Inc. (VIAP) | 20-Jan-05 | Payment of Exercise | 13,447 | $5.19 | $69,789.90 | (20%) 66.57K to 53.12K | 100% |
| 24-Jan-05 11:52 AM View: | Otto Richard E Chief Executive Officer Director | VIA Pharmaceuticals, Inc. (VIAP) | 20-Jan-05 | Option Exercise | 39,881 | $1.75 | $69,791.80 | 81% 49.38K to 89.27K | |
| 24-Jan-05 11:52 AM View: | Otto Richard E Chief Executive Officer Director | VIA Pharmaceuticals, Inc. (VIAP) | 20-Jan-05 | Payment of Exercise | 13,447 | $5.19 | $69,789.90 | (15%) 89.27K to 75.82K | 100% |
| 24-Jan-05 11:52 AM View: | Atwood Robert T CFO, Executive VP Director | VIA Pharmaceuticals, Inc. (VIAP) | 20-Jan-05 | Option Exercise | 39,881 | $1.75 | $69,791.80 | 149% 26.69K to 66.57K | |
| 17-May-04 10:00 PM View: | Falkenberg Eric N Director | VIA Pharmaceuticals, Inc. (VIAP) | 12-May-04 | Market Purchase | 12,500 | $6.09 | $76,125.00 | 125% 10.0K to 22.5K | (100%) |
| 17-May-04 10:00 PM View: | Falkenberg Eric N Director | VIA Pharmaceuticals, Inc. (VIAP) | 12-May-04 | Market Purchase | 12,500 | $5.99 | $74,875.00 | 56% 22.5K to 35.0K | (100%) |
| 11-May-04 10:00 PM View: | Callicutt Jack W VP-Finance&Admin, Chf Acct Off | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 1,000 | $5.50 | $5,500.00 | 100% 0 to 1.0K | (100%) |
| 11-May-04 10:00 PM View: | Larson John Randolph Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 18,000 | $5.50 | $99,000.00 | 44% 41.23K to 59.23K | (100%) |
| 11-May-04 10:00 PM View: | Royston Ivor Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 10,909 | $5.50 | $59,999.50 | 9% 116.05K to 126.96K | (100%) |
| 11-May-04 10:00 PM View: | Otto Richard E Chief Executive Officer Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 5,000 | $5.50 | $27,500.00 | 19% 26.41K to 31.41K | (100%) |
| 11-May-04 10:00 PM View: | Falkenberg Eric N Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 10,000 | $5.50 | $55,000.00 | 100% 0 to 10.0K | (100%) |
| 11-May-04 10:00 PM View: | Merriman Ronald Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 1,500 | $5.50 | $8,250.00 | 100% 0 to 1.5K | (100%) |
| 11-May-04 10:00 PM View: | Schmitt Victor W Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 10,000 | $5.50 | $55,000.00 | 211% 4.73K to 14.73K | (100%) |
| 11-May-04 10:00 PM View: | Gilstrap James C Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 25,000 | $5.50 | $137,500.00 | 43% 58.33K to 83.33K | (100%) |
| 11-May-04 10:00 PM View: | Nichol F Richard Phd Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 1,000 | $5.50 | $5,500.00 | 100% 0 to 1.0K | (100%) |
| 11-May-04 10:00 PM View: | Atwood Robert T CFO, Executive VP Director | VIA Pharmaceuticals, Inc. (VIAP) | 07-May-04 | Market Purchase | 5,000 | $5.50 | $27,500.00 | 23% 21.69K to 26.69K | (100%) |
